PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
9 hedge funds and large institutions have $9.94M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
7.13% more ownership
Funds ownership: 6.48% → 13.62% (+7.1%)
10% less funds holding
Funds holding: 10 → 9 (-1)
14% less capital invested
Capital invested by funds: $11.6M → $9.94M (-$1.67M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$9.23M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$198K |
| 3 |
Jane Street
New York
|
+$154K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$57K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$3.61M |
| 2 |
CC
Cannell & Co
New York
|
-$150K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.4K |
| 4 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$12K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$6K |
PHXM Hedge Fund Activity: Q4 2021 in Review
9 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q4 2021, worth a combined $9.94M — down 14% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PHXM and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $9.23M. The largest seller was NEA Management Company, exiting entirely with an estimated $3.61M sold.
- 9 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q4 2021, down from 10 in Q3 2021.
- Funds reported $9.94M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q4 2021, down 14% quarter-over-quarter.
- 4 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q4 2021 and 5 closed out, a net change of -1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q4 2021 was Armistice Capital, an estimated $9.23M added.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q4 2021 was NEA Management Company, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2021.